These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17146446)

  • 1. KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer.
    Bloch M; Ousingsawat J; Simon R; Schraml P; Gasser TC; Mihatsch MJ; Kunzelmann K; Bubendorf L
    Oncogene; 2007 Apr; 26(17):2525-34. PubMed ID: 17146446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer.
    Ruiz C; Holz DR; Oeggerli M; Schneider S; Gonzales IM; Kiefer JM; Zellweger T; Bachmann A; Koivisto PA; Helin HJ; Mousses S; Barrett MT; Azorsa DO; Bubendorf L
    J Pathol; 2011 Mar; 223(4):543-52. PubMed ID: 21294127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of KCNMA1 in breast cancer.
    Oeggerli M; Tian Y; Ruiz C; Wijker B; Sauter G; Obermann E; Güth U; Zlobec I; Sausbier M; Kunzelmann K; Bubendorf L
    PLoS One; 2012; 7(8):e41664. PubMed ID: 22899999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of urokinase gene in prostate cancer.
    Helenius MA; Saramäki OR; Linja MJ; Tammela TL; Visakorpi T
    Cancer Res; 2001 Jul; 61(14):5340-4. PubMed ID: 11454671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry.
    Lallet-Daher H; Roudbaraki M; Bavencoffe A; Mariot P; Gackière F; Bidaux G; Urbain R; Gosset P; Delcourt P; Fleurisse L; Slomianny C; Dewailly E; Mauroy B; Bonnal JL; Skryma R; Prevarskaya N
    Oncogene; 2009 Apr; 28(15):1792-806. PubMed ID: 19270724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCM7 amplification and overexpression are associated with prostate cancer progression.
    Ren B; Yu G; Tseng GC; Cieply K; Gavel T; Nelson J; Michalopoulos G; Yu YP; Luo JH
    Oncogene; 2006 Feb; 25(7):1090-8. PubMed ID: 16247466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor amplification is associated with increased cell proliferation in prostate cancer.
    Haapala K; Kuukasjärvi T; Hyytinen E; Rantala I; Helin HJ; Koivisto PA
    Hum Pathol; 2007 Mar; 38(3):474-8. PubMed ID: 17217995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic and expression analysis of the 3q25-q26 amplification unit reveals TLOC1/SEC62 as a probable target gene in prostate cancer.
    Jung V; Kindich R; Kamradt J; Jung M; Müller M; Schulz WA; Engers R; Unteregger G; Stöckle M; Zimmermann R; Wullich B
    Mol Cancer Res; 2006 Mar; 4(3):169-76. PubMed ID: 16547154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells.
    Ummanni R; Teller S; Junker H; Zimmermann U; Venz S; Scharf C; Giebel J; Walther R
    FEBS J; 2008 Nov; 275(22):5703-13. PubMed ID: 18959755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-level TOP2A amplification in prostate cancer is associated with HER2 duplication, androgen resistance, and decreased survival.
    Murphy AJ; Hughes CA; Barrett C; Magee H; Loftus B; O'Leary JJ; Sheils O
    Cancer Res; 2007 Mar; 67(6):2893-8. PubMed ID: 17363613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular pathology of prostate carcinoma. Academic playground or guide for diagnosis and therapy planning?].
    Bubendorf L
    Verh Dtsch Ges Pathol; 2004; 88():158-64. PubMed ID: 16892547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
    Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
    Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in the KCNMA1 potassium channel alpha subunit as risk factor for severe essential hypertension and myocardial infarction.
    Tomás M; Vázquez E; Fernández-Fernández JM; Subirana I; Plata C; Heras M; Vila J; Marrugat J; Valverde MA; Sentí M
    J Hypertens; 2008 Nov; 26(11):2147-53. PubMed ID: 18854754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancer.
    Mäki HE; Saramäki OR; Shatkina L; Martikainen PM; Tammela TL; van Weerden WM; Vessella RL; Cato AC; Visakorpi T
    J Pathol; 2007 Aug; 212(4):395-401. PubMed ID: 17503439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocytic trafficking signals in KCNMB2 regulate surface expression of a large conductance voltage and Ca(2+)-activated K+ channel.
    Zarei MM; Song M; Wilson RJ; Cox N; Colom LV; Knaus HG; Stefani E; Toro L
    Neuroscience; 2007 Jun; 147(1):80-9. PubMed ID: 17521822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered cryptal expression of luminal potassium (BK) channels in ulcerative colitis.
    Sandle GI; Perry MD; Mathialahan T; Linley JE; Robinson P; Hunter M; MacLennan KA
    J Pathol; 2007 May; 212(1):66-73. PubMed ID: 17405186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TREK-1 is a novel molecular target in prostate cancer.
    Voloshyna I; Besana A; Castillo M; Matos T; Weinstein IB; Mansukhani M; Robinson RB; Cordon-Cardo C; Feinmark SJ
    Cancer Res; 2008 Feb; 68(4):1197-203. PubMed ID: 18281496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q; Titus MA; Fung KM; Lin HK
    J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning of potassium channel splice variants from tissues and cells.
    Chen L; Shipston MJ
    Methods Mol Biol; 2008; 491():35-60. PubMed ID: 18998082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
    Yu S; Wang X; Ng CF; Chen S; Chan FL
    Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.